Page 138 - 2020年17期
P. 138
[40] NIEMINEN TH,HAGELBERG NM,SAARI TI,et al. timicrob Chemother,2019,74(1):3291-3294.
Oxycodone concentrations are greatly increased by the [51] 张影,张福奎.《2016 年欧洲肝病学会丙型肝炎治疗指
concomitant use of ritonavir or lopinavir/ritonavir[J]. Eur 南》推 荐 意 见 [J]. 临 床 肝 胆 病 杂 志 ,2016,32(12):
J Clin Pharmacol,2010,66(10):977-985. 2248-2257.
[41] GRUN B,MERKEL U,RIEDEL KD,et al.Contribution [52] ROLLINS B,FAROUK S,DEBOCCARDO G,et al.
of CYP2C19 and CYP3A4 to the formation of the active Higher rates of rejection in HIV-infected kidney transplant
nortilidine from the prodrug tilidine[J]. Br J Clin Pharma- recipients on ritonavir-boosted protease inhibitors:3-year
col,2012,74(5):854-863. follow-up study[J]. Clin Transplant,2019.DOI:10.1111/
[42] YOUNIS IR,LAKOTA EA,VOLPE DA,et al. Drug-drug ctr.13534.
interaction studies of methadone and antiviral drugs:les- [53] 李航,张刚,王建,等.西地那非联合小剂量他达拉非治疗
sons learned[J]. J Clin Pharmacol,2019,59(8):1035- 重度勃起功能障碍的临床观察[J].现代泌尿外科杂志,
1043. 2020,25(5):428-430.
[43] VICTORRI-VIGNEAU C,VERSTUYFT C,BOUQUIE [54] 杨洋,曾卉,李方园,等.药代动力学过程中的中西药配伍
R,et al.Relevance of CYP2B6 and CYP2D6 genotypes to 禁忌[J].中药与临床,2018,9(5):45-49.
methadone pharmacokinetics and response in the OPAL [55] XU Y,ZHANG YF,CHEN XY,et al. CYP3A4 inducer
study[J]. Br J Clin Pharmacol,2019,85(7):1538-1543. and inhibitor strongly affect the pharmacokinetics of trip-
[44] LOZANO R,DOMEQUE N,FRUTOS AJ.Methadone tolide and its derivative in rats[J]. Acta Pharmacol Sin,
dosing in patients on ritonavir-boosted-based highly ac- 2018,39(8):1386-1392.
tive antiretroviral therapy[J]. Med Clin:Barc,2019,152 [56] CIFUENTES MD,BLANCO LS,RAMIREZ FC. Ergo-
(4):161-162. tism due to simultaneous use of ergot alkaloids and high
[45] LIM ML,MIN SS,ERON JJ,et al.Coadministration of activity antiretroviral therapy[J]. Rev Med Chil,2016,144
lopinavir/ritonavir and phenytoin results in two-way drug (6):807-812.
interaction through cytochrome P-450 induction[J]. J Ac- [57] FERRY FR,DA SG,MOTTA RN,et al. Use of lopinavir/
quir Immune Defic Syndr,2004,36(5):1034-1040. ritonavir associated with ergotamine resulting in foot am-
[46] LEE MJ,DAWOOD L,HOFSTEDE HJ,et al. Lopinavir/ putation:brief communication[J]. Rev Inst Med Trop Sao
ritonavir reduces lamotrigine plasma concentrations in Paulo,2014,56(3):265-266.
healthy subjects[J]. Clin Pharmacol Ther,2006,80(2): [58] 孙涛,王江蓉,陈军,等. HIV 感染者中唐草片对洛匹那
159-168. 韦药动学的影响[J].中国现代应用药学,2016,33(9):
[47] SHEEHAN NL,BROUILLETTE MJ,DELISLE MS,et al. 1119-1123.
Possible interaction between lopinavir/ritonavir and val- [59] BAEZA MT,MERINO E,BOIX V,et al. Nifedipine-lopi-
proic acid exacerbates bipolar disorder[J]. Ann Pharmaco- navir/ritonavir severe interaction:a case report[J]. AIDS,
ther,2006,40(1):147-150. 2007,21(1):119-120.
[48] SAMPSON MR,CAO KY,GISH PL,et al.Dosing recom- [60] CHINELLO P,CICALINI S,PICHINI S,et al. Sildenafil
mendations for quetiapine when coadministered with HIV and bosentan plasma concentrations in a human immuno-
protease inhibitors[J]. J Clin Pharmacol,2019,59(4): deficiency virus- infected patient with pulmonary arterial
500-509. hypertension treated with ritonavir-boosted protease inhib-
[49] GREENBLATT DJ,VON MOLTKE LL,HARMATZ JS, itor[J]. Infect Dis Rep,2015.DOI:10.4081/idr.2015.5822.
et al. Short-term exposure to low-dose ritonavir impairs [61] MCDONALD CR,CONROY AL,GAMBLE JL,et al. Es-
clearance and enhances adverse effects of trazodone[J]. J tradiol levels are altered in human immunodeficiency vi-
Clin Pharmacol,2003,43(4):414-422. rus-infected pregnant women randomized to efavirenz-ver-
[50] PEYRO-SAINT-PAUL L,BESNIER P,DEMESSINE L, sus lopinavir/ritonavir-based antiretroviral therapy[J]. Clin
et al.Cushing’s syndrome due to interaction between rito- Infect Dis,2018,66(3):428-436.
navir or cobicistat and corticosteroids:a case-control (收稿日期:2020-04-26 修回时间:2020-07-22)
study in the French Pharmacovigilance Database[J]. J An- (编辑:罗 瑞)
·2176 · China Pharmacy 2020 Vol. 31 No. 17 中国药房 2020年第31卷第17期